Compound Summary

  Compound Information

TCMBANKIN008919

药名:	isoguvacine
别名:	MLS000859962; Isoguvacine hydrochloride, solid; I02-4338; SR-01000075611-3; 1,2,3,6-tetrahydro-4-pyridinecarboxylicacidhydrochloride; Lopac-G-002; G-002; SY012592; KBio1_000115; SMR000326821; 1,2,3,6-tetrahydropyridine-4-carboxylic acid; IDI1_000115; NCGC00093946-02; 1,2,3,6-Tetrahydro-pyridine-4-carboxylic acid hydrochloride; Tocris-0235; EU-0100561; Isoguvacine (hydrochloride); ISOGUVACINE HYDROCHLORIDE; NINDS_000115; 68547-97-7; SUWREQRNTXCCBL-UHFFFAOYSA-N; HY-100810; NCGC00024509-03; NCGC00093946-03; NCGC00015456-01; SCHEMBL7958625; TRA0081918; B6230; 1,2,3,6-Tetrahydro-4-pyridinecarboxylic acid hydrochloride; MFCD00055192; NCGC00024509-01; TR-022104; SPECTRUM1502129; Biomol-NT_000254; Isoguvacine; LP00561; SR-01000075611; KBio3_002820; FT-0670465; I0871; Spectrum_001974; SC-49605; C13694; AX8223448; 4-Pyridinecarboxylic acid, 1,2,3,6-tetrahydro-, hydrochloride; AKOS025243370; BPBio1_000882; 1,2,3,6-Tetrahydro-pyridine-4-carboxylic acid hydr; KBio2_007667; 4-Pyridinecarboxylic acid, 1,2,3,6-tetrahydro-; KS-00000AIF; MolPort-003-983-601; CCG-221865; BSPBio_003318; 1,2,3,6-Tetrahydro-4-pyridinecarboxylic acid; Lopac0_000561; AKOS015847455; NCGC00093946-01; 64603-90-3 (Parent); AK154352; 1,2,3,6-TETRAHYDRO-4-PYRIDINECARBOXYLIC ACID HCL; 1,2,3,6-Tetrahydro-pyridine-4-carboxylic acidhydrochloride; Tox21_500561; BN0277; KBio2_002531; SC-49604; AC1L4DMR; 1,2,3,6-tetrahydropyridine-4-carboxylic acid hydrochloride; CS-6967; SR-01000075611-1; DTXSID00218663; 1,2,5,6,-Tetrahydroisonicotinic acid Hydrochloride; KBioSS_002540; KBio2_005099; CHEMBL540303; Spectrum3_001869; Z-2044; NCGC00261246-01; DivK1c_000115; Isoguvacine HCl; 1,2,5,6-tetrahydroisonicotinic acid hydrochloride
分子式:	C6H9NO2
Smiles:	C1CNCC=C1C(=O)O
成分:	HBIN030788
OB_score:	72.172209
CAS_id:	64603-90-3
SymMap_id:	SMIT00237
TCMID_id:	23242
TCMSP_id:	MOL005838
PubChem_id:	3765

---

   化合物对应的植物

植物ID	拉丁名	药用植物名	药名	来源	功能与主治	使用民族

TCMBANKHE002321	Semen Arecae Preparata	焦槟榔			Treatment of retention of undigested food, dysentery with tenesmus./Treatment of retention of undigested food, dysentery with tenesmus.
TCMBANKHE003895		大腹皮			Its decoction exerts an effect of enhancing the intestinal tensity and decreasing the extent of intestinal contraction in rabbits in vitro, which can be counteracted by atropine.
TCMBANKHE007924	semen arecae	槟榔			1. To kill parasites; 2. To promote qi circulation; 3. To promote water metabolism/Wormccumulation, food stagnation, distending pain in stomach duct and abdomen, diarrhea and tenesmus, beriberi, edema, malaria.
TCMBANKHE005980/YEM-13	herba Menthae;Mentha haplocalyx Briq|Mentha haplocalyx Briq.	薄荷	薄荷	云南民族药物志：第一卷	To dispel wind-heat from the head and eyes, and to promote eruption./Chronic urticaria, infection of upper respiratory tract, sarcoma, wind-heat exterior syndrome, headache and red eyes, swelling pain in throat, non-eruption of measles, dormant papules with pruritus, liver depression and rib-side pain, abdominal distention.	阿昌族/傣族/德昂族/哈尼族/景颇族/傈僳族/彝族
TCMBANKHE005203/YEM-999/XU-341	Radix Isatidis seu Baphicacanthi|Isatis indigotica Fort.|Isatis indigotica	板蓝根|菘蓝	板蓝根	云南民族药物志：第五卷|山东省菏泽市	To remove toxic heat, to reduce heat in blood, and to soothe sore throat./Epidemic encephalitis, measles papulis, parotitis, influenza, warm toxin macular eruption, ardent fever with headache, massive head scourge, throat pain, maculopapular eruption, epidemic parotitis, erysipelas, hepatitis, swelling toxin of sore and welling abscess.	回族/彝族

---

   植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

---

   化合物对应的靶点

靶点ID	基因名	基因别名	描述

TCMBANKGE000813	DPP4	ADABP; ADCP2; CD26; DPPIV; TP103	dipeptidyl peptidase 4
TCMBANKGE006886	ADH1A	ADH1	alcohol dehydrogenase 1A (class I), alpha polypeptide
TCMBANKGE009389	LYZ	LYZF1; LZM	lysozyme
TCMBANKGE011079	PRSS1	TRP1; TRY1; TRY4; TRYP1	serine protease 1
TCMBANKGE012171	GABBR1	GABABR1; GABBR1-3; GB1; GPRC3A	gamma-aminobutyric acid type B receptor subunit 1
TCMBANKGE014050	GABRA1	ECA4; EIEE19; EJM; EJM5	gamma-aminobutyric acid type A receptor subunit alpha1